# Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy

> **NCT04401553** · PHASE4 · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Surgical Site Infection
- Beta-lactam Allergy

## Interventions

- **DRUG:** cephalosporin
- **DRUG:** Second tier antibiotic (Vancomycin)

## Key facts

- **NCT ID:** NCT04401553
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-08-16
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study never initiated.
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04401553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04401553, "Prophylactic Antibiotics for Surgical Site Infections and Beta-Lactam Allergy". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04401553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*